Application Category,Application,No. of R01 (% in application),No. of U01 (% in application),No. of R44 (% in application),No. of R21 (% in application),Total number of awards
Biochemical analysis,Cell signaling pathways,74 (63%),11 (9%),3 (3%),11 (9%),117
Biochemical analysis,Drug discovery,67 (43%),0 (0%),8 (5%),13 (8%),156
Biochemical analysis,Mass spectroscopy,104 (72%),3 (2%),3 (2%),8 (6%),145
Biochemical analysis,Other chemical compound characterization,65 (41%),10 (6%),14 (9%),12 (8%),159
Biochemical analysis,Protein structure and binding prediction,69 (53%),10 (8%),7 (5%),6 (5%),130
Biochemical analysis,Small molecule interactions,41 (51%),2 (2%),3 (4%),4 (5%),81
Cancer,Breast cancer,132 (44%),26 (9%),8 (3%),25 (8%),297
Cancer,Other cancer,156 (42%),48 (13%),9 (2%),24 (6%),375
Cancer,Prostate cancer,61 (48%),10 (8%),2 (2%),22 (17%),127
Cardiovascular,Cardiovascular disease,99 (53%),1 (1%),6 (3%),11 (6%),186
Data types,Big data,35 (26%),5 (4%),5 (4%),4 (3%),135
Data types,Motion tracking and artifact reduction,76 (51%),2 (1%),10 (7%),14 (9%),150
Data types,Text mining,131 (60%),9 (4%),7 (3%),9 (4%),220
Data types,Wearable devices and mobile technology,93 (48%),14 (7%),8 (4%),23 (12%),193
Electronic health record,Electronic health record,139 (47%),28 (9%),2 (1%),22 (7%),296
Endocrine,Diabetes,47 (41%),13 (11%),2 (2%),10 (9%),114
Endocrine,Metabolic syndrome and metabolic processes,63 (64%),8 (8%),2 (2%),3 (3%),99
Environmental health,Environmental health,105 (52%),4 (2%),1 (0%),19 (9%),203
Genetics,Clinically significant genetic variation,127 (54%),37 (16%),1 (0%),4 (2%),236
Genetics,Familial genetics,61 (47%),28 (22%),3 (2%),0 (0%),129
Genetics,Functional mutations,89 (55%),16 (10%),3 (2%),9 (6%),162
Genetics,Gene mapping,101 (61%),6 (4%),2 (1%),8 (5%),166
Genetics,Molecular genetics,120 (49%),12 (5%),16 (7%),15 (6%),246
Genetics,Mouse modeling,85 (51%),10 (6%),5 (3%),19 (11%),167
Genetics,Population genetics,89 (68%),9 (7%),5 (4%),6 (5%),130
Genetics,Regulatory genetics,184 (66%),20 (7%),4 (1%),4 (1%),280
Genetics,RNA analysis,57 (49%),0 (0%),6 (5%),9 (8%),116
Hepatic,Liver disease,65 (53%),24 (20%),0 (0%),9 (7%),123
Infectious disease/Immunologic,HIV,102 (42%),13 (5%),4 (2%),27 (11%),243
Infectious disease/Immunologic,Immunology,67 (39%),12 (7%),4 (2%),13 (8%),170
Infectious disease/Immunologic,Other infectious disease,83 (34%),20 (8%),2 (1%),35 (14%),242
Injuries/trauma,Trauma,75 (47%),8 (5%),3 (2%),25 (16%),159
Knowledge frameworks,Centers for translational and computational research,17 (12%),13 (9%),1 (1%),2 (1%),144
Knowledge frameworks,Intelligent search engines and data visualization,28 (37%),3 (4%),1 (1%),1 (1%),76
Knowledge frameworks,Knowledge bases,61 (35%),12 (7%),2 (1%),4 (2%),176
Knowledge frameworks,Knowledge representation and reasoning,80 (66%),0 (0%),4 (3%),5 (4%),122
Knowledge frameworks,Literature review,34 (45%),0 (0%),0 (0%),5 (7%),76
Knowledge frameworks,Ontology generation,59 (60%),4 (4%),5 (5%),2 (2%),99
Language and communication,Interpersonal communication technologies,49 (53%),5 (5%),4 (4%),5 (5%),92
Language and communication,Language development and reading comprehension,159 (59%),14 (5%),10 (4%),21 (8%),271
Language and communication,Social media and social behavior,121 (57%),6 (3%),5 (2%),18 (8%),212
Language and communication,Speech,134 (64%),7 (3%),10 (5%),14 (7%),210
Mental health,Adolescent psychiatry,49 (32%),16 (10%),5 (3%),12 (8%),155
Mental health,Alcohol use,70 (32%),53 (24%),0 (0%),15 (7%),218
Mental health,Autism spectrum disorder,92 (48%),3 (2%),11 (6%),17 (9%),192
Mental health,Depression,43 (41%),8 (8%),6 (6%),9 (9%),104
Mental health,Other child development,75 (46%),7 (4%),1 (1%),9 (5%),164
Mental health,Other mental health,55 (37%),4 (3%),6 (4%),5 (3%),148
Mental health,Pain,97 (52%),0 (0%),4 (2%),17 (9%),188
Mental health,Schizophrenia,57 (50%),4 (4%),0 (0%),16 (14%),113
Mental health,Suicidality,42 (53%),3 (4%),3 (4%),5 (6%),79
Model types,Deep learning,98 (44%),9 (4%),13 (6%),35 (16%),221
Model types,Natural language processing,68 (56%),9 (7%),1 (1%),12 (10%),121
Model types,Unspecified classification models,63 (48%),1 (1%),10 (8%),10 (8%),131
Neurologic,Alzheimer's disease,176 (55%),17 (5%),8 (2%),21 (7%),321
Neurologic,EEG,43 (41%),4 (4%),20 (19%),7 (7%),104
Neurologic,Memory,73 (49%),4 (3%),0 (0%),8 (5%),149
Neurologic,Motor function,101 (53%),11 (6%),5 (3%),14 (7%),192
Neurologic,Neural circuits,199 (55%),21 (6%),3 (1%),21 (6%),361
Neurologic,Other dementia,71 (48%),0 (0%),19 (13%),8 (5%),148
Neurologic,Sleep,37 (37%),0 (0%),10 (10%),11 (11%),101
Neurologic,Stroke,89 (51%),0 (0%),0 (0%),11 (6%),176
Population health,Population health screening,62 (41%),2 (1%),12 (8%),18 (12%),151
Patient safety,Adverse drug events/drug safety,129 (49%),12 (5%),15 (6%),16 (6%),265
Patient safety,Other patient safety,73 (63%),0 (0%),8 (7%),5 (4%),115
Patient safety,Surgical planning,71 (52%),2 (1%),9 (7%),17 (12%),137
Population health,Older adults,94 (55%),0 (0%),1 (1%),9 (5%),171
Population health,Pediatrics,26 (41%),4 (6%),2 (3%),9 (14%),63
Renal,Kidney disease,58 (47%),0 (0%),4 (3%),13 (11%),123
Respiratory,Asthma,25 (27%),5 (5%),2 (2%),12 (13%),93
Respiratory,Lung cancer and COPD,113 (52%),6 (3%),4 (2%),17 (8%),217
Training and education,Student training and education,29 (19%),0 (0%),17 (11%),0 (0%),149
Vision,Object tracking and recognition,75 (66%),0 (0%),2 (2%),6 (5%),113
Vision,Visual impairment,37 (47%),0 (0%),2 (3%),7 (9%),78
Vision,Visual processing,120 (71%),0 (0%),6 (4%),9 (5%),168
